“Przemek brings a wealth of finance experience across the health and life sciences sectors. His impressive track record, entrepreneurial drive and connectivity with preeminent investment firms globally make him uniquely qualified to lead our financial strategy. Broadening our executive team will allow us to execute our growth strategy, scale our operations and advance our position as a global leader in cell programming." Mark Kotter, Founder and CEO, bit.bio
bit.bio expand Executive Team with appointment of Przemek Obloj as Chief Financial Officer
6 August 2024
Cambridge, UK – bit.bio, the company coding human cells for novel cures and a pioneer in the field of synthetic biology, announces the appointment of Przemek Obloj as Chief Financial Officer. Mr. Obloj will oversee the company’s financial strategy, including fundraising, and work closely with Founder and CEO, Mark Kotter, and the Executive Team to support continued growth and innovation.
